4//SEC Filing
Berger Dietmar 4
Accession 0001739515-26-000002
CIK 0000882095other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 5:56 PM ET
Size
8.3 KB
Accession
0001739515-26-000002
Insider Transaction Report
Form 4
Berger Dietmar
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2026-01-02+16,326→ 16,326 total - Tax Payment
Common Stock
2026-01-02$121.60/sh−6,944$844,390→ 9,382 total - Exercise/Conversion
Restricted Stock Unit
2026-01-02−16,326→ 41,179 total→ Common Stock (16,326 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- [F2]The restricted stock units vest in approximately three equal installments on the first three anniversaries of the date of grant until fully vested.
Documents
Issuer
GILEAD SCIENCES, INC.
CIK 0000882095
Entity typeother
Related Parties
1- filerCIK 0001739515
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 5:56 PM ET
- Size
- 8.3 KB